Molecular Vision Strengthens Board, Appoints Dr Chris Hand as Non-Executive Director

15-Apr-2010 - United Kingdom

Molecular Vision has announced the appointment of Dr Chris Hand as a Non-Executive Director with immediate effect. The appointment serves to strengthen the Board as the Company moves towards commercialisation of its novel detection technology, which focuses on low cost diagnostic tests in a miniaturised, easy-to-use, disposable format.

Dr Hand has over 20 years’ experience in the medical diagnostics market. He was CEO of medical diagnostics company Cozart plc until its acquisition by Concateno plc in October 2007. Dr Hand co-founded Cozart with £30,000 in 1993, led a successful VC fundraising in 2001 and AIM flotation in 2004 before the £65m sale of the business in late 2007. He remained a non-executive director of Concateno until its acquisition by Inverness Medical Innovations in 2009. Dr Hand has a DPhil in biochemistry from Oxford University.

Other news from the department people

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance